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Volume 50, Number 1 Abstracts 237gelatine hydrogel microspheres (AGHMs) for the treatment of peripheral
arterial disease (PAD).
Materials and methods:We conducted a non-randomised and uncon-
trolled trial involving prospective observation of eight patients (eight limbs)
with PAD — five limbs with arteriosclerosis obliterans and three limbs with
thromboangiitis obliterans, five limbs (three arms and two legs) with critical
limb ischaemia (CLI) and three limbs with intermittent claudication (IC)—
who were followed up for 6 months or more. AGHM suspension containing
100 g bFGF was infused into the artery of the affected limb. Besides
evaluation of safety and changes in symptoms, resting ankle–brachial pres-
sure index measurement and transcutaneous PO2 (tcPO2), angiography
were conducted at baseline and then at various time points. Skin perfusion
pressure as an index of CLI and claudication distance as an index of IC were
also used to assess clinical improvement and limb perfusion.
Results: No serious adverse events were observed. All cases showed
improvement in symptoms, although this was temporary in some patients.
Conclusion: Selective delivery of bFGF using AGHMs was suggested
to be safe and well-tolerated in patients with PAD.
Increased Metabolic Activity in Abdominal Aortic Aneurysm Detected by
18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography/
Computed Tomography (PET/CT)
Kotze C.W., Menezes L.J., Endozo R., Groves A.M., Ell P.J., Yusuf S.W.
Eur J Vasc Endovasc Surg 2009;38:93-99.
Objectives:Abdominal aortic aneurysms (AAAs) are associated with an
inflammatory cell infiltrate and enzymatic degradation of the vessel wall. The
aim of this study was to detect increased metabolic activity in the wall of the
AAA with 18F-fluorodeoxyglucose (18F-FDG), mediated by glucose trans-
porter protein (GLUTs), using a dedicated hybrid PET/64-detector CT.
Design, method and materials: 14 patients (All male, mean age 73.6
years, range 61–82) with AAA under surveillance underwent PET/CT
scanning with 175 MBq of intravenous I8F-FDG. The maximum aneurysm
diameter and calcification score were determined on the attenuation correc-
tion CT. A volume of interest was placed on the aneurysm sac and the
maximum Standardised Uptake Value (SUVmax) measured.
Results: The mean aneurysm diameter was 5.4 cm (SD  0.8). Two
aneurysms had the CT characteristics of inflammatory aneurysms. Twelve
aneurysms showed increased FDG uptake (SUVmax  2.5). There was no
significant difference in FDG uptake between heavily calcified aneurysms
and non-heavily calcified aneurysms (t-test). There was a significant increaseReaders can access EJVES articles at http://intl.eConclusion: The findings in this study offer in vivo evidence that the
AAA wall shows increased glucose metabolism, mediated by the GLUTs:
this increased metabolic activity as detected by PET/CT may be present in
most AAAs.
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tive Lesions: Long-Term Results
Hartung O., Loundou A.D., Barthelemy P., Arnoux D., Boufi M., Alimi
Y.S. Eur J Vasc Endovasc Surg 2009;38:118-124.
Objective: To report the long-term results of stenting for chronic
ilio-caval obstructive lesions.
Material and methods: From January 1996 to January 2008, 89
patients (72 women, 17 men; median age 43 years) were admitted for
endovascular treatment of chronic disabling non-malignant obstructive
ilio-caval lesions. Patients were classified as C2 in 15 cases, C3 in 59,
C4 in seven, C5 in two and C6 in six. Median preoperative venous
disability score (VDS) and venous clinical severity score (VCSS) were 2
and 9, respectively. Aetiology was primary in 52 patients, secondary in 35
and congenital in two. Lesions were bilateral in seven cases, eight patients
had inferior vena cava (IVC) involvement and 18 had common femoral
vein (CFV) obstructive lesions. Complete occlusion was found in 30
cases.
Results: Technical success was achieved in 98%. The median hospital
stay was 2 days. During a median follow-up of 38 months (range: 1–144
months), one patient died and five cases of thromboses occurred. Iterative
stenting was performed for restenosis in six cases. Primary, assisted-primary
and secondary patency rates, in terms of intention to treat, were 83%, 89%
and 93%, respectively, at 3 and 10 years, with a median VDS of 1. Univariate
analysis found that significant factors affecting patency were CFV involve-
ment for primary patency and history of deep venous thrombosis (DVT) and
CFV involvement for secondary patency.
The last 46 patients had statistically more severe lesions than the first 43
(higher VDS, more secondary lesions, more occlusions, more stented seg-
ments, higher length of stented vein), and in spite of which patency rates are
not different.
Conclusion: Endovenous angioplasty, combined with stenting, is a
sure, safe, effective and very minimally invasive technique which provides
good long-term patency rates. Currently, it is recognised as the technique ofin the FDG uptake in the two inflammatory aneurysms compared to the
other twelve aneurysms (t-test; P  0.04).
choice for the treatment of ilio-caval obstructive lesions. Surgery should be
proposed only in case of failure.lsevierhealth.com/journals/ejvs/default.cfm
